CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3,322 enrolled
Drug / intervention
Blood sampling for genomics; harvesting of a sample of intercostal muscle for proteomics (thoracotomies only)procedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00812734
NCT00812734N/ACompleted

Etude épidémiologique Multicentrique Des Douleurs Neuropathiques Post-opératoires

University Hospital, Clermont-Ferrand·observational·Posted Dec 22, 2008·Updated May 28, 2019

In Brief

An observational study evaluating Blood sampling for genomics; harvesting of a sample of intercostal muscle for proteomics (thoracotomies only) for Neuropathic Pain. Completed, enrolled 3,322 participants across 1 site.

Detailed Summary

This cohort study aims to know the prevalence at 3 and 6 months after surgery, of persistent pain, as well as to describe the neuropathic features of this pain. It includes more than 3000 patients scheduled for different types of surgery, some of them already known to induce persistent pain, some being frequent procedures with no additional data. Clinical and genetical risk factors will be searched.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesFrance
CollaboratorsPfizer

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 22, 2008
Enrollment StartApr 1, 2006
Primary CompletionMar 1, 2010
Study CompletionSep 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 17.5 years ago

Interventions

Blood sampling for genomics; harvesting of a sample of intercostal muscle for proteomics (thoracotomies only)procedure

Blood sampling for genomics; harvesting of a sample of intercostal muscle for proteomics (thoracotomies only)